Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI (PH110)

Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI (PH110)

Solidify competitive intelligence’s presence to optimize decision making

Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities.

Recent years have seen CI groups on the upswing. Their role is evolving and developing a greater emphasis on adding strategic value. At the same time, CI’s budgets and staffing are increasing. Recent trends in structuring have led to increased efficiency. These are certainly encouraging signs, and CI groups are adapting to the changes.

But there is still much work to be done. CI teams still must fight for resources to succeed. They must also demonstrate their value and trumpet their successes. To not only survive, but to thrive as a function, CI must attract top talent, increase its reach and create a CI culture within an organization.

Pharmaceutical Competitive Intelligence examines top companies’ practices to provide a guide for improving CI efforts. This report presents the focal points of the research in three chapters:

* Structuring for Success – Provides details on CI structures, including global-level reporting lines and placements; ways in which CI team trumpet their successes and create CI cultures; and the career paths laid out to make CI teams breeding grounds for future pharma leaders

* Resourcing for Growth – Reveals CI department-level budgets and staffing; brand-level phase-by-phase spending and staffing, which groups fund CI; and how companies demonstrate ROI on CI

* Increasing CI’s Reach – Examines how companies communicate their strategic value to internal clients and the resources and tools for collecting CI

Companies Included in Report

AstraZeneca

Baxter

Bristol-Myers Squibb

Cephalon

Daiichi Sankyo

DePuy

Forest Laboratories

GeneraMedix

Genzyme

Janssen-Cilag

Johnson & Johnson

Merck

Nycomed

Watson Pharmaceuticals

….plus more

Published 2008

116 Pages

300+ Metrics

60+ Charts and Diagrams
Table of Contents
Price: $7,695.00 / €5,147.96

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions